Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Warehouse club giant Costco has struck a deal with Novo Nordisk to make the Danish drug maker's weight loss drugs Wegovy and Ozempic available to the retailer's members for $499 a month. Ozempic's ...

Mounjaro recorded sales of Rs 85 crore in September. Analysts say user-friendly pen formulation helped build the momentum, expected to get a further boost from GST cuts ...

BBB National Programs’ National Advertising Division reviewed a challenge brought by Novo Nordisk, Inc. regarding express and implied advertising claims made by Medicine Center Pharmacy (MCP) ...

Novo Nordisk, the company that owns both Wegovy and Ozempic, will be selling the medicine at nearly half the out-of-pocket price of other pharmacies at just $499. The company’s U.S. president David ...

Endocrinologists say the early momentum for Mounjaro was expected, given its dual indication for diabetes and obesity ...

Shares of Costco (NASDAQ:COST) have finally entered correction territory, dipping by close to 14% from its all-time highs. Indeed, buying the dip in the beloved bulk-buy retailer has paid off in a big ...

BBB National Programs’ National Advertising Division reviewed a challenge brought by Novo Nordisk, Inc. regarding express and implied advertising claims made ...

Mounjaro recorded Rs 80 crore in sales in September, trailing only GSK's antibiotic Augmentin, which registered Rs 85 crore ...

Warehouse club giant Costco has struck a deal with Novo Nordisk to make the Danish drug maker's weight loss drugs Wegovy and Ozempic available to the retailer's members for $499 a month. Ozempic's ...

(KVOA) - Popular weight loss medications are now available on store shelves at retailers Costco and Sam's Club. Ozempic and Wegovy are known for their appetite-suppressing qualities, helping people to ...

Hims & Hers HealthHIMS is Wednesday's IBD Stock Of The Day. After returning to the IBD 50, Hims stock is making a second attempt at a breakout since late July.The telehealth giant announced its ...